The biopharmaceutical company said Tuesday that Aqvesme is now the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia.

This study was led by Dr. Salim Hayek and published in the Journal of Clinical Investigation. It could lead to a major change ...

New ACC/AHA guidelines update management of adults with congenital heart defects but highlight the shortage of specialists ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy (R) pill, the first oral GLP-1 medicine for obesity in the US. (3) Wegovy (R) pill is used ...

Birth control pills, taken alone or paired with the drug metformin, did not raise the risk of metabolic syndrome, a precursor ...

New EU guidance outlines steps on prevention, screening, and access to care as cardiovascular deaths are projected to climb sharply in coming decades.

Vitamin C is vital to immune function and the maintenance of bone, skin, teeth, and joints. Learn more about its wide range of health benefits.

A large new study has found that people with high blood pressure are more likely to stick with their treatment if they start ...

Women with severe coronary heart disease causing narrowing or blockages in the arteries may derive greater long-term benefits ...

Congenital heart disease (CHD) management has evolved substantially over recent decades, with transcatheter and hybrid interventions now providing minimally ...

Amid news of the splashy $4.8 billion Amicus buy, BioMarin has slipped in the discontinuation of a genetic liver disease ...

Stifel analysts said the label for cardiac myosin inhibitor Myqorzo is in line with their expectations and is differentiated compared with BMS’ Camzyos.